Law360, New York (August 08, 2012, 4:53 PM ET) -- A New York federal judge on Tuesday dismissed two North China Pharmaceutical Group Corp. units from a multidistrict price-fixing litigation against Chinese vitamin C companies, but found the suit's allegations strong enough to keep cartel claims against the parent company alive.
U.S. District Judge Brian M. Cogan dismissed North China Pharmaceutical Co. Ltd. and North China Pharmaceutical Group International Trade Co. Ltd. — which the judge referred to as NCPC Limited and NCPC I&E, respectively — from the MDL for lack of personal jurisdiction, saying the...
2 North China Pharma Units Exit Vitamin C Antitrust MDL
To view the full article, take a free trial now.
